Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -3.71% vs 11.72% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -23.84% vs 20.25% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -9.13% vs 7.38% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 8.63% vs 17.20% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Nanjing Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -3.71% vs 11.72% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 3.33% vs 0.10% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -23.84% vs 20.25% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -18.15% vs 4.37% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -9.13% vs 7.38% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -14.08% vs 1.90% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 8.63% vs 17.20% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -7.59% vs -15.34% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






